Pacira Pharmaceuticals, Nuance Biotech Report License Agreement for EXPAREL in China; Pacira Grants Nuance Rights To Develop And Commercialize EXPAREL In China For An Upfront Payment Of $3m And Is Eligible For Milestone Payments Of $55M
Benzinga Newsdesk